Mar 06, 2023 - Mar 08, 2023 / 03:30PM GMT
Yaron Benjamin Werber - TD Cowen, Research Division - MD & Senior Biotechnology Analyst
Conference. I'm Yaron Werber from the biotech team. And it's a great pleasure to moderate the panel with argenx with my colleague Brendan Smith. So the management really needs no introduction. We have Tim Van Hauwermeiren, the CEO; and Keith Woods, COO. Gentlemen, thanks so much for joining us. We appreciate it.
Timothy Van Hauwermeiren - argenx SE - CEO & Executive Director
Thanks for having us.
Questions and Answers:
Yaron Benjamin Werber - TD Cowen, Research Division - MD & Senior Biotechnology AnalystSo there's a lot to talk about. There's a launch underway that's been going well. There's an upcoming PDUFA for subcu. Their CIDP data coming up, and there's obviously a lot of pipeline data. And Keith, there's obviously news with you that we want to cover.
Let's talk maybe first. The launch has gone very well in the U.S., launch is obviously slower in Europe because of pricing and the
Trustpilot
